Effect of metformin therapy on vitamin D level in patients with type 2 diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 2
Abstract
Background. Recent studies have shown that patients with diabetes mellitus (DM) often have skeletal disorders, in particular, reduced bone mineral density, osteoporosis. Apart from the disease itself, the nature of hypoglycemic therapy can make a significant contribution to increasing the risk of diabetes mellitus. The aim of the study was to evaluate the effect of metformin on the serum vitamin D level in patients with type 2 DM. Materials and methods. There were 47 patients under observation. The main group (n = 25) included patients who suffered from type 2 DM and received treatment with metformin, a hypoglycemic drug. The control group consisted of apparently healthy persons (n = 22). The study excludes patients with pathology of parathyroid glands, thyroid function disorders, kidney disease, and those taking vitamin D or calcium. Levels of 25-hydroxyvitamin D (25(OH)D), parathormone, ionized calcium, glycated hemoglobin (HbA1c) were evaluated. Results. Forty-seven patients aged 42 to 69 years (average age 58.0 ± 17.5 years) were examined. A study of serum 25(OH)D level showed that in most patients it was low. The average level of 25(OH)D in the main group was 18.37 ± 7.62 ng/ml (5.89–32.8 ng/ml). The study showed a higher prevalence of vitamin D deficiency among patients with type 2 DM (66.7 %) receiving metformin than in the control group (7.69 %). It was found that vitamin D levels were lower in patients with poorer glycemic control of type 2 DM (HbA1c > 7 %) — 15.03 ± 7.60 ng/ml and 22.75 ± 7.62 ng/ml, respectively. Conclusions. The study showed a higher prevalence of vitamin D deficiency among patients with type 2 DM (66.7 %) receiving metformin than in the control group (7.69 %). A reliable inverse correlation was found between the elevated HbA1c level and reduced 25(OH)D content. The level of 25(OH)D was significantly lower in the main group of patients receiving metformin therapy compared to the control group.
Authors and Affiliations
K. O. Masliy
Keywords
Related Articles
- EP ID EP605134
- DOI 10.22141/2224-0721.15.2.2019.166105
- Views 41
- Downloads 0
Iodine Support of Population in Vinnytsa Region
In 9 localities in Vinnitsa region the study of iodine support of population was conducted. 810 persons were examined including 540 children aged 7–12 years old living under the conditions of combined influence of geoche...
Epidemiological Aspects of Diabetes Mellitus in Tashkent on the Basis of Register Data
The objective of research — an analysis of epidemiological aspects of diabetes mellitus (DM) type 1 and 2 in Tashkent. Materials and methods. Analysis of DM register was performed on the basis of the map registers in Ta...
Child’s Intellect and Iodine Deficiency: Mechanisms of Negative Impact and Ways of Prevention
The paper presents a review of scientific literature on the effect of iodine deficiency on the intellectual development of the child. The conclusion was made about the need for a mass iodine prophylaxis in the population...
Characteristics of specific immunological indicators in patients with postoperative relapse of Graves’ disease
Background. Activity of autoimmune processes had a leading role in the development of relapse of hyperthyroidism. Level of thyroid-stimulating hormone (TSH) receptor antibodies is a basic factor that predetermines the re...
Male hypogonadism (part 2)
The second part of the review shows the current approaches to the methods of diagnosis and treatment of various forms of hypogonadism in men.